Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality usin...
Saved in:
Published in | The Lancet global health Vol. 5; no. 10; pp. e984 - e991 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.10.2017
The Lancet Global Health Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data.
In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables.
We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 months (2·0–10·0) in upper middle-income countries, and 7·0 months (3·6–16·8) in high-income countries.
This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries.
Bill & Melinda Gates Foundation. |
---|---|
AbstractList | Background: Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. Methods: In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. Findings: We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 years (2·0–10·0) in upper middle-income countries, and 7·0 years (3·6–16·8) in high-income countries. Interpretation: This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Funding: Bill & Melinda Gates Foundation. Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. Methods In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. Findings We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 months (2·0–10·0) in upper middle-income countries, and 7·0 months (3·6–16·8) in high-income countries. Interpretation This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 months (2·0–10·0) in upper middle-income countries, and 7·0 months (3·6–16·8) in high-income countries. This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Bill & Melinda Gates Foundation. Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data.BACKGROUNDRespiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data.In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables.METHODSIn this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables.We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3-11·0) in low-income or lower middle-income countries, 4·0 years (2·0-10·0) in upper middle-income countries, and 7·0 years (3·6-16·8) in high-income countries.FINDINGSWe studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3-11·0) in low-income or lower middle-income countries, 4·0 years (2·0-10·0) in upper middle-income countries, and 7·0 years (3·6-16·8) in high-income countries.This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries.INTERPRETATIONThis study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries.Bill & Melinda Gates Foundation.FUNDINGBill & Melinda Gates Foundation. Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3-11·0) in low-income or lower middle-income countries, 4·0 years (2·0-10·0) in upper middle-income countries, and 7·0 years (3·6-16·8) in high-income countries. This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Bill & Melinda Gates Foundation. |
Author | Thorburn, Kentigern Papenburg, Jesse Chi, Hsin Lucion, Florencia Madhi, Shabir A Khuri-Bulos, Najwa Sánchez, José F O'Brien, Katherine L Paes, Bosco A Goka, Edward A Gessner, Bradford D Lucero, Marilla G Nair, Harish de-Paris, Fernanda Moyes, Jocelyn Munywoki, Patrick K Halasa, Natasha Lopez, Olga Bont, Louis J Gordon, Aubree Sutanto, Agustinus Grobbee, Diederick E Oshitani, Hitoshi Groome, Michelle J Ito, Hisato Lupisan, Socorro P Ali, Asad Gentile, Angela Cohen, Cheryl Simões, Eric A F Bassat, Quique da Costa Oliveira, Maria Tereza de Freitas Lázaro Emediato, Carla Cecília Thamthitiwat, Somsak Aamir, Uzma Bashir Polack, Fernando P Pires, Márcia Rosane Butt, Warwick Roglić, Srđan Mejias, Asuncion Scheltema, Nienke M Rath, Barbara A Ramilo, Octavio Fasce, Rodrigo A Nokes, D James Leung, Ting F Spaeder, Michael C |
AuthorAffiliation | l Department of Virology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Miyagi, Japan p International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA ar University of Nottingham School of Medicine, Nottingham, UK am Department of Virology, National Institute of Health, Islamabad, Pakistan aa Department of Pediatrics and Center for Global Health, University of Colorado, Aurora, CO, USA ay Julius Clinical Science, Zeist, Netherlands ae ICREA, Catalan Institution for Research and Advanced Studies, Barcelona, Spain d Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya h School of Public Health, University of the Witwatersrand, Johannesburg, South Africa c Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina ai Department of Intensive Care, Royal Children's Hospital, Melbourne, VIC, Australia z Neonatal Division, Department of |
AuthorAffiliation_xml | – name: j Department of Paediatric Intensive Care, Alder Hey Children's Hospital, Liverpool, UK – name: ag Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique – name: q Agence de Medecine Preventive, Paris, France – name: av Department of Pediatrics, Nantan General Hospital, Ueno, Yagichoyagi, Nantan-shi, Kyoto, Japan – name: r West Nusa Tenggara Provincial Government, Lombok, Indonesia – name: aq Vienna Vaccine Safety Initiative, Berlin, Germany – name: ar University of Nottingham School of Medicine, Nottingham, UK – name: ad ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain – name: i Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa – name: ay Julius Clinical Science, Zeist, Netherlands – name: t Center for Vaccines and Immunity at Nationwide Children's Hospital, Ohio State University, Columbus, OH, USA – name: az Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK – name: v Vanderbilt University Medical Center, Nashville, TN, USA – name: ao Public Health Institute, Ñuñoa, Santiago, Chile – name: at Department of Microbiology, Division of Pediatric Infectious Diseases, McGill University Health Centre, Montreal, QC, Canada – name: h School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – name: af Department of Pediatrics, Hospital Sant Joan de Déu, Barcelona, Spain – name: am Department of Virology, National Institute of Health, Islamabad, Pakistan – name: e School of Life Sciences, University of Warwick, Coventry, UK – name: u Department of Pediatrics, University of Jordan, Aljubeiha, Amman, Jordan – name: au Department of Paediatric Infectious Diseases, University Hospital for Infectious Diseases, Zagreb, Croatia – name: k Division of Global Health Protection, Thailand Ministry of Public Health—US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand – name: ae ICREA, Catalan Institution for Research and Advanced Studies, Barcelona, Spain – name: f Department of Nursing Sciences, Pwani University, Kilifi, Kenya – name: ap Hospital Dr. Ernesto Torres Galdames, Iquique, Chile – name: s Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus, OH, USA – name: d Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya – name: l Department of Virology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Miyagi, Japan – name: p International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – name: aa Department of Pediatrics and Center for Global Health, University of Colorado, Aurora, CO, USA – name: w Molecular Biology Laboratory, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil – name: z Neonatal Division, Department of Pediatrics, McMaster University, Hamilton, ON, Canada – name: ai Department of Intensive Care, Royal Children's Hospital, Melbourne, VIC, Australia – name: b ReSViNET Respiratory Syncytial Virus Network, Utrecht, Netherlands – name: aj Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia – name: c Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina – name: ax Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands – name: an Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan – name: a Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands – name: ak Murdoch Children's Research Institute, Parkville, VIC, Australia – name: g Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa – name: ah Faculty of Medicine, Universidad Europea de Madrid, Madrid, Spain – name: y Division of Pediatric Critical Care, University of Virginia School of Medicine, Charlottesville, VA, USA – name: x Infection Control Commission, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil – name: al Department of Pediatric Infectious Disease, MacKay Children's Hospital, Taipei, Taiwan – name: ab Department of Paediatrics, Faculty of Medicine and Chinese University of Hong Kong-University Medical Center Utrecht Joint Research Laboratory of Respiratory Virus and Immunobiology, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region, China – name: as Fundacion Infant, Buenos Aires, Argentina – name: n Department of Epidemiology, School of Public Health, University of Michigan, MI, USA – name: m Research Institute for Tropical Medicine, Alabang Muntinlupa City, Metro Manila Philippines – name: aw School of Health and Related Research, University of Sheffield, Sheffield, UK – name: o Department of Medicine, Hospital Infantil Manuel de Jesus Rivera, Managua, Nicaragua – name: ac Health Secretariat of the City of Belo Horizonte, Belo Horizonte, Brazil |
Author_xml | – sequence: 1 givenname: Nienke M surname: Scheltema fullname: Scheltema, Nienke M organization: Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands – sequence: 2 givenname: Angela surname: Gentile fullname: Gentile, Angela organization: Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina – sequence: 3 givenname: Florencia surname: Lucion fullname: Lucion, Florencia organization: Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina – sequence: 4 givenname: D James surname: Nokes fullname: Nokes, D James organization: Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya – sequence: 5 givenname: Patrick K surname: Munywoki fullname: Munywoki, Patrick K organization: Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya – sequence: 6 givenname: Shabir A surname: Madhi fullname: Madhi, Shabir A organization: Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa – sequence: 7 givenname: Michelle J surname: Groome fullname: Groome, Michelle J organization: Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa – sequence: 8 givenname: Cheryl surname: Cohen fullname: Cohen, Cheryl organization: School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – sequence: 9 givenname: Jocelyn surname: Moyes fullname: Moyes, Jocelyn organization: Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa – sequence: 10 givenname: Kentigern surname: Thorburn fullname: Thorburn, Kentigern organization: Department of Paediatric Intensive Care, Alder Hey Children's Hospital, Liverpool, UK – sequence: 11 givenname: Somsak surname: Thamthitiwat fullname: Thamthitiwat, Somsak organization: Division of Global Health Protection, Thailand Ministry of Public Health—US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand – sequence: 12 givenname: Hitoshi surname: Oshitani fullname: Oshitani, Hitoshi organization: Department of Virology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Miyagi, Japan – sequence: 13 givenname: Socorro P surname: Lupisan fullname: Lupisan, Socorro P organization: Research Institute for Tropical Medicine, Alabang Muntinlupa City, Metro Manila Philippines – sequence: 14 givenname: Aubree surname: Gordon fullname: Gordon, Aubree organization: Department of Epidemiology, School of Public Health, University of Michigan, MI, USA – sequence: 15 givenname: José F surname: Sánchez fullname: Sánchez, José F organization: Department of Medicine, Hospital Infantil Manuel de Jesus Rivera, Managua, Nicaragua – sequence: 16 givenname: Katherine L surname: O'Brien fullname: O'Brien, Katherine L organization: International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – sequence: 17 givenname: Bradford D surname: Gessner fullname: Gessner, Bradford D organization: Agence de Medecine Preventive, Paris, France – sequence: 18 givenname: Agustinus surname: Sutanto fullname: Sutanto, Agustinus organization: West Nusa Tenggara Provincial Government, Lombok, Indonesia – sequence: 19 givenname: Asuncion surname: Mejias fullname: Mejias, Asuncion organization: Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus, OH, USA – sequence: 20 givenname: Octavio surname: Ramilo fullname: Ramilo, Octavio organization: Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus, OH, USA – sequence: 21 givenname: Najwa surname: Khuri-Bulos fullname: Khuri-Bulos, Najwa organization: Department of Pediatrics, University of Jordan, Aljubeiha, Amman, Jordan – sequence: 22 givenname: Natasha surname: Halasa fullname: Halasa, Natasha organization: Vanderbilt University Medical Center, Nashville, TN, USA – sequence: 23 givenname: Fernanda surname: de-Paris fullname: de-Paris, Fernanda organization: Molecular Biology Laboratory, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil – sequence: 24 givenname: Márcia Rosane surname: Pires fullname: Pires, Márcia Rosane organization: Infection Control Commission, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil – sequence: 25 givenname: Michael C surname: Spaeder fullname: Spaeder, Michael C organization: Division of Pediatric Critical Care, University of Virginia School of Medicine, Charlottesville, VA, USA – sequence: 26 givenname: Bosco A surname: Paes fullname: Paes, Bosco A organization: Neonatal Division, Department of Pediatrics, McMaster University, Hamilton, ON, Canada – sequence: 27 givenname: Eric A F surname: Simões fullname: Simões, Eric A F organization: Department of Pediatrics and Center for Global Health, University of Colorado, Aurora, CO, USA – sequence: 28 givenname: Ting F surname: Leung fullname: Leung, Ting F organization: Department of Paediatrics, Faculty of Medicine and Chinese University of Hong Kong-University Medical Center Utrecht Joint Research Laboratory of Respiratory Virus and Immunobiology, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region, China – sequence: 29 givenname: Maria Tereza surname: da Costa Oliveira fullname: da Costa Oliveira, Maria Tereza organization: Health Secretariat of the City of Belo Horizonte, Belo Horizonte, Brazil – sequence: 30 givenname: Carla Cecília surname: de Freitas Lázaro Emediato fullname: de Freitas Lázaro Emediato, Carla Cecília organization: Health Secretariat of the City of Belo Horizonte, Belo Horizonte, Brazil – sequence: 31 givenname: Quique surname: Bassat fullname: Bassat, Quique organization: ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain – sequence: 32 givenname: Warwick surname: Butt fullname: Butt, Warwick organization: Department of Intensive Care, Royal Children's Hospital, Melbourne, VIC, Australia – sequence: 33 givenname: Hsin surname: Chi fullname: Chi, Hsin organization: Department of Pediatric Infectious Disease, MacKay Children's Hospital, Taipei, Taiwan – sequence: 34 givenname: Uzma Bashir surname: Aamir fullname: Aamir, Uzma Bashir organization: Department of Virology, National Institute of Health, Islamabad, Pakistan – sequence: 35 givenname: Asad surname: Ali fullname: Ali, Asad organization: Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan – sequence: 36 givenname: Marilla G surname: Lucero fullname: Lucero, Marilla G organization: Research Institute for Tropical Medicine, Alabang Muntinlupa City, Metro Manila Philippines – sequence: 37 givenname: Rodrigo A surname: Fasce fullname: Fasce, Rodrigo A organization: Public Health Institute, Ñuñoa, Santiago, Chile – sequence: 38 givenname: Olga surname: Lopez fullname: Lopez, Olga organization: Hospital Dr. Ernesto Torres Galdames, Iquique, Chile – sequence: 39 givenname: Barbara A surname: Rath fullname: Rath, Barbara A organization: Vienna Vaccine Safety Initiative, Berlin, Germany – sequence: 40 givenname: Fernando P surname: Polack fullname: Polack, Fernando P organization: Fundacion Infant, Buenos Aires, Argentina – sequence: 41 givenname: Jesse surname: Papenburg fullname: Papenburg, Jesse organization: Department of Microbiology, Division of Pediatric Infectious Diseases, McGill University Health Centre, Montreal, QC, Canada – sequence: 42 givenname: Srđan surname: Roglić fullname: Roglić, Srđan organization: Department of Paediatric Infectious Diseases, University Hospital for Infectious Diseases, Zagreb, Croatia – sequence: 43 givenname: Hisato surname: Ito fullname: Ito, Hisato organization: Department of Pediatrics, Nantan General Hospital, Ueno, Yagichoyagi, Nantan-shi, Kyoto, Japan – sequence: 44 givenname: Edward A surname: Goka fullname: Goka, Edward A organization: School of Health and Related Research, University of Sheffield, Sheffield, UK – sequence: 45 givenname: Diederick E surname: Grobbee fullname: Grobbee, Diederick E organization: Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands – sequence: 46 givenname: Harish surname: Nair fullname: Nair, Harish organization: Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK – sequence: 47 givenname: Louis J surname: Bont fullname: Bont, Louis J email: l.bont@umcutrecht.nl organization: Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28911764$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt9v0zAQxyM0xMbYnwDK4_YQ8M8kBgFCA8qkSpMYIN4sx7l0Hm7c2U6l_Pc4bam2vQxLlu3zfT_n893z7KB3PWTZS4xeY4TLN1eEYFZgJH6f4uqMIspYQZ9kR3vzwZ39YXYSwg1KQwhKqupZdkhqgXFVsqPsdmZdo2zuIayMV9H5MQ9jr8doknVt_BAKFYLTRkVo86XzUVkTx9z0-eiGfpHra2NbD31--v3qVz67nH8-e5urBIzehRXoaNaQaxUgD-ANhBfZ007ZACe79Tj7-fXLj_NvxfxydnH-aV7okohY8LbElHeEN4xB2_GWUFITRIVihHEloKkRKzkVVQk16kgDyRfXlCa7ajWix9nFlts6dSNX3iyVH6VTRm4Mzi-k8tFoC7LEXUc7zlEpNNO1aKCkpGGkqSrOgYrE-rBlrYZmCa2GPnpl70Hv3_TmWi7cWnKe_hyxBMBbgA6Dlh40eK3iRrg_TJOgikgiaFlNQU93Qb27HSBEuTRBg7WqBzcEiQVDiAkqplxf3X3f_mH_6pwc-C5-Kkrw0O1dMJJTS8lNS8mpXySu5KalJE26dw902kQVjZvSNPZR9cetGlKd1wa8DNpAr6E1KeuYCmEeJbx_QNDW9EYr-wfG_9D_BYXL-Qo |
CitedBy_id | crossref_primary_10_1055_s_0042_1760446 crossref_primary_10_1002_ppul_25435 crossref_primary_10_1093_cid_ciab488 crossref_primary_10_1002_14651858_CD010473_pub4 crossref_primary_10_1152_ajpheart_00018_2021 crossref_primary_10_1186_s12982_021_00104_5 crossref_primary_10_1155_2020_8919534 crossref_primary_10_1093_cid_ciab486 crossref_primary_10_1097_INF_0000000000002271 crossref_primary_10_1016_j_meegid_2019_03_026 crossref_primary_10_1186_s12887_021_02675_3 crossref_primary_10_1016_j_clim_2019_108324 crossref_primary_10_1002_14651858_CD010473_pub3 crossref_primary_10_1097_INF_0000000000003121 crossref_primary_10_1016_j_dche_2024_100214 crossref_primary_10_1016_S2214_109X_17_30348_0 crossref_primary_10_1177_20499361221128091 crossref_primary_10_1093_infdis_jiac078 crossref_primary_10_1128_jvi_01341_22 crossref_primary_10_1891_0730_0832_11_T_693 crossref_primary_10_1016_S2542_5196_20_30297_7 crossref_primary_10_1542_peds_2020_1727 crossref_primary_10_1002_jmv_25917 crossref_primary_10_1097_INF_0000000000003416 crossref_primary_10_1016_j_arcmed_2019_10_005 crossref_primary_10_1021_acsinfecdis_9b00524 crossref_primary_10_1007_s40475_018_0156_4 crossref_primary_10_5812_ijp_89082 crossref_primary_10_1007_s40272_023_00598_3 crossref_primary_10_1186_s12887_019_1649_6 crossref_primary_10_1016_j_diagmicrobio_2019_04_006 crossref_primary_10_1016_j_vaccine_2021_03_096 crossref_primary_10_3390_v12050521 crossref_primary_10_3389_fgene_2021_633125 crossref_primary_10_1080_17476348_2020_1807945 crossref_primary_10_1007_s10096_018_3409_1 crossref_primary_10_1093_infdis_jiac481 crossref_primary_10_1097_INF_0000000000003538 crossref_primary_10_1186_s12879_020_4882_6 crossref_primary_10_1007_s10096_019_03588_x crossref_primary_10_1128_jvi_02029_24 crossref_primary_10_1016_j_cyto_2019_154965 crossref_primary_10_1093_ve_veaa050 crossref_primary_10_1016_j_xcrm_2023_101081 crossref_primary_10_1002_ppul_24804 crossref_primary_10_1007_s13312_024_3310_1 crossref_primary_10_1002_rmv_2284 crossref_primary_10_1016_j_aller_2019_10_007 crossref_primary_10_1016_j_biopha_2021_111843 crossref_primary_10_1016_j_sste_2021_100434 crossref_primary_10_3389_fcimb_2019_00075 crossref_primary_10_3389_fped_2025_1482029 crossref_primary_10_1186_s12879_022_07261_1 crossref_primary_10_3390_v15040993 crossref_primary_10_1016_S1473_3099_18_30292_5 crossref_primary_10_1099_jgv_0_001287 crossref_primary_10_1097_INF_0000000000003747 crossref_primary_10_1111_irv_12893 crossref_primary_10_1111_irv_12771 crossref_primary_10_3390_ijerph17020564 crossref_primary_10_1016_j_vaccine_2018_06_021 crossref_primary_10_1371_journal_pmed_1004250 crossref_primary_10_1002_ppul_23963 crossref_primary_10_1097_INF_0000000000002666 crossref_primary_10_1093_cid_ciy413 crossref_primary_10_1097_INF_0000000000004682 crossref_primary_10_1111_irv_12639 crossref_primary_10_1093_infdis_jiaa046 crossref_primary_10_2196_13377 crossref_primary_10_1080_14787210_2019_1581062 crossref_primary_10_1055_s_0041_1731409 crossref_primary_10_1093_cid_ciz585 crossref_primary_10_1186_s12879_024_10024_9 crossref_primary_10_1002_14651858_CD004873_pub6 crossref_primary_10_3389_fmicb_2023_1173842 crossref_primary_10_1097_01_JAA_0000694944_22382_39 crossref_primary_10_1016_j_ajic_2021_10_027 crossref_primary_10_1016_j_virs_2025_01_003 crossref_primary_10_1093_infdis_jiz161 crossref_primary_10_3390_pathogens13090802 crossref_primary_10_1002_ppul_25114 crossref_primary_10_1016_j_lanepe_2024_100965 crossref_primary_10_1016_j_eclinm_2021_100945 crossref_primary_10_1164_rccm_201712_2567OC crossref_primary_10_1371_journal_ppat_1011597 crossref_primary_10_1542_hpeds_2022_006542 crossref_primary_10_7554_eLife_46202 crossref_primary_10_1016_j_jped_2022_10_004 crossref_primary_10_1097_INF_0000000000004375 crossref_primary_10_1186_s12978_018_0528_1 crossref_primary_10_3390_ijms241411445 crossref_primary_10_1128_JVI_01407_20 crossref_primary_10_1590_1984_0462_2024_42_2022215 crossref_primary_10_1007_s00431_018_3168_0 crossref_primary_10_1128_JVI_01201_20 crossref_primary_10_1016_j_antiviral_2023_105791 crossref_primary_10_1016_j_cpem_2018_02_011 crossref_primary_10_1128_JVI_01322_17 crossref_primary_10_28982_josam_632224 crossref_primary_10_3389_fped_2022_979777 crossref_primary_10_1136_thoraxjnl_2020_216291 crossref_primary_10_1080_14787210_2018_1543589 crossref_primary_10_1016_S2213_2600_20_30109_0 crossref_primary_10_3390_antiox10121874 crossref_primary_10_1016_j_aller_2019_04_004 crossref_primary_10_1093_infdis_jiaa309 crossref_primary_10_1002_jcph_1140 crossref_primary_10_1093_infdis_jiaa424 crossref_primary_10_1007_s40121_020_00390_7 crossref_primary_10_1016_j_vaccine_2018_10_041 crossref_primary_10_1016_S1473_3099_22_00291_2 crossref_primary_10_3390_v15081760 crossref_primary_10_1371_journal_ppat_1009428 crossref_primary_10_3390_vaccines7010003 crossref_primary_10_1093_ofid_ofae679 crossref_primary_10_1007_s40203_023_00178_w crossref_primary_10_1093_infdis_jiae467 crossref_primary_10_2217_fvl_2020_0174 crossref_primary_10_1056_NEJMoa2106062 crossref_primary_10_3390_metabo12020178 crossref_primary_10_3389_fimmu_2024_1438630 crossref_primary_10_3390_v13122478 crossref_primary_10_1016_j_vaccine_2020_04_075 crossref_primary_10_1038_s41467_021_23859_6 crossref_primary_10_53126_MEB41632 crossref_primary_10_1021_acsomega_8b01600 crossref_primary_10_1080_14787210_2021_1828866 crossref_primary_10_1136_thoraxjnl_2018_212212 crossref_primary_10_1093_cid_ciz017 crossref_primary_10_3390_vaccines9090961 crossref_primary_10_1093_infdis_jiaa751 crossref_primary_10_1097_INF_0000000000002297 crossref_primary_10_1177_2515135520981516 crossref_primary_10_3390_children9060848 crossref_primary_10_1016_j_prrv_2019_04_003 crossref_primary_10_1016_j_ijid_2022_10_039 crossref_primary_10_1080_21645515_2020_1843336 crossref_primary_10_1126_scitranslmed_aaw0268 crossref_primary_10_1007_s00431_018_03308_1 crossref_primary_10_3389_fped_2022_997349 crossref_primary_10_3390_v13061023 crossref_primary_10_1080_14737159_2018_1487293 crossref_primary_10_1097_INF_0000000000003398 crossref_primary_10_1542_hpeds_2020_005702 crossref_primary_10_3390_children10061081 crossref_primary_10_1093_cid_ciab497 crossref_primary_10_1016_j_meegid_2024_105694 crossref_primary_10_1089_vim_2018_0121 crossref_primary_10_1126_scitranslmed_ade6422 crossref_primary_10_2217_fca_2017_0096 crossref_primary_10_1183_23120541_00135_2020 crossref_primary_10_3390_biomimetics7010003 crossref_primary_10_3998_lacs_7017 crossref_primary_10_1038_s41598_021_88524_w crossref_primary_10_1093_jpids_piad042 crossref_primary_10_1080_14760584_2023_2189459 crossref_primary_10_3389_fcimb_2022_858629 crossref_primary_10_7189_jogh_13_04001 crossref_primary_10_3390_microorganisms13010140 crossref_primary_10_1093_cid_ciab528 crossref_primary_10_3390_vaccines8020177 crossref_primary_10_1164_rccm_201810_1921OC crossref_primary_10_4049_jimmunol_2100018 crossref_primary_10_1038_s41591_019_0392_8 crossref_primary_10_1186_s12879_021_06544_3 crossref_primary_10_1016_j_jvacx_2023_100379 |
Cites_doi | 10.1093/infdis/jit479 10.1016/j.vaccine.2015.05.093 10.1007/s00431-010-1376-3 10.1542/peds.2014-2151 10.1016/S0140-6736(12)61728-0 10.1185/03007995.2010.505126 10.1001/jama.2010.675 10.1186/1756-0500-6-447 10.1007/s15010-008-8130-z 10.1164/rccm.201603-0658OC 10.1016/S0140-6736(12)61901-1 10.1371/journal.pone.0089978 10.1093/infdis/jit517 10.1136/jech.2004.026450 10.1136/adc.2008.139188 10.1542/peds.2013-0303 10.1097/INF.0000000000001163 10.1371/journal.pone.0018176 10.1086/317655 10.1016/j.jmii.2014.08.020 10.1016/j.vaccine.2016.02.078 10.1111/ped.12051 10.1007/s15010-013-0557-1 10.1097/INF.0000000000001262 10.1016/S0929-6646(11)60057-0 10.1016/S2213-2600(15)00255-6 10.1016/S0140-6736(17)30938-8 |
ContentType | Journal Article |
Copyright | 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. cc by (c) Scheltema et. al, 2017 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2017 |
Copyright_xml | – notice: 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license – notice: Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. – notice: cc by (c) Scheltema et. al, 2017 info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a> – notice: 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2017 |
CorporateAuthor | PERCH Study Group |
CorporateAuthor_xml | – name: PERCH Study Group |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 XX2 5PM DOA |
DOI | 10.1016/S2214-109X(17)30344-3 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Recercat PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 2214-109X |
EndPage | e991 |
ExternalDocumentID | oai_doaj_org_article_61ff3f55069c4c89be632b42b7755e39 PMC5599304 oai_recercat_cat_2072_293679 28911764 10_1016_S2214_109X_17_30344_3 S2214109X17303443 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation | Bill & Melinda Gates Foundation. |
GrantInformation_xml | – fundername: Wellcome Trust – fundername: NCIRD CDC HHS grantid: U01 IP001048 |
GroupedDBID | .1- .FO 0R~ 1P~ 457 53G AAEDT AAEDW AAIKJ AALRI AAMRU AAXUO AAYWO ABMAC ACGFS ACHQT ACVFH ADBBV ADCNI ADEZE ADVLN AENEX AEUPX AEVXI AEXQZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HZ~ IPNFZ IXB KQ8 M41 M~E O9- OD. OK1 OO~ RIG ROL SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 XX2 5PM |
ID | FETCH-LOGICAL-c629t-5d6135f25b44edf5d23282039a4245a9eb804653976e80f2bef251833b80adc03 |
IEDL.DBID | IXB |
ISSN | 2214-109X |
IngestDate | Wed Aug 27 01:25:20 EDT 2025 Thu Aug 21 13:55:45 EDT 2025 Fri Aug 29 12:36:20 EDT 2025 Fri Jul 11 00:26:23 EDT 2025 Thu Apr 03 07:00:20 EDT 2025 Thu Apr 24 22:53:57 EDT 2025 Tue Jul 01 00:52:22 EDT 2025 Wed May 17 01:33:45 EDT 2023 Tue Aug 26 16:32:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c629t-5d6135f25b44edf5d23282039a4245a9eb804653976e80f2bef251833b80adc03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Contributed equally |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S2214109X17303443 |
PMID | 28911764 |
PQID | 1940049390 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_61ff3f55069c4c89be632b42b7755e39 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5599304 csuc_recercat_oai_recercat_cat_2072_293679 proquest_miscellaneous_1940049390 pubmed_primary_28911764 crossref_primary_10_1016_S2214_109X_17_30344_3 crossref_citationtrail_10_1016_S2214_109X_17_30344_3 elsevier_sciencedirect_doi_10_1016_S2214_109X_17_30344_3 elsevier_clinicalkey_doi_10_1016_S2214_109X_17_30344_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-10-01 |
PublicationDateYYYYMMDD | 2017-10-01 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The Lancet global health |
PublicationTitleAlternate | Lancet Glob Health |
PublicationYear | 2017 |
Publisher | Elsevier Ltd The Lancet Global Health Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: The Lancet Global Health – name: Elsevier |
References | Do, van Doorn, Nghiem (bib4) 2011; 6 Berger, Aebi, Duppenthaler, Stocker (bib25) 2009; 37 Giersing, Modjarrad, Kaslow, Moorthy (bib20) 2016; 34 (accessed May 3, 2016). Shi, McAllister, O'Brien (bib5) 2017 Shay, Holman, Roosevelt, Clarke, Anderson (bib8) 2001; 183 Mccracken, Prill, Arvelo (bib19) 2013; 208 Leung, Lam, Miu (bib17) 2014; 42 Butt, Symington, Janes, Elliott, Steele, Paes (bib14) 2011; 170 Zhang, Guo, Langley, Bai (bib7) 2013; 6 Lee, Peng, Chiu, Huang, Huang, Chi (bib10) 2016; 49 Mauskopf, Margulis, Samuel, Lohr (bib27) 2016; 35 Mazur, Martinón-Torres, Baraldi (bib28) 2015; 3 Chi, Chang, Tsai (bib26) 2011; 110 Nair, Simões, Rudan (bib29) 2013; 381 WHO. Child growth standards. Moyes, Cohen, Pretorius (bib18) 2013; 208 Modjarrad, Giersing, Kaslow, Smith, Moorthy (bib21) 2016; 34 Hall, Weinberg, Blumkin (bib15) 2013; 132 Fleming, Pannell, Cross (bib6) 2005; 59 The World Bank. Country and lending groups. Welliver, Checchia, Bauman, Fernandes, Mahadevia, Hall (bib12) 2010; 26 Thorburn (bib11) 2009; 94 / Geoghegan, Erviti, Caballero (bib16) 2017; 195 Byington, Wilkes, Korgenski, Sheng (bib24) 2014; 135 Nasreen, Luby, Brooks (bib3) 2014; 9 El Kholy, Mostafa, El-Sherbini (bib9) 2013; 55 Berkley, Munywoki, Ngama (bib2) 2010; 303 Lozano, Naghavi, Foreman (bib1) 2012; 380 Vizcarra-Ugalde, Rico-Hernández, Monjarás-Ávila (bib13) 2016; 35 Mccracken (10.1016/S2214-109X(17)30344-3_bib19) 2013; 208 Fleming (10.1016/S2214-109X(17)30344-3_bib6) 2005; 59 Giersing (10.1016/S2214-109X(17)30344-3_bib20) 2016; 34 Do (10.1016/S2214-109X(17)30344-3_bib4) 2011; 6 Welliver (10.1016/S2214-109X(17)30344-3_bib12) 2010; 26 Shi (10.1016/S2214-109X(17)30344-3_bib5) 2017 Mauskopf (10.1016/S2214-109X(17)30344-3_bib27) 2016; 35 Berkley (10.1016/S2214-109X(17)30344-3_bib2) 2010; 303 Butt (10.1016/S2214-109X(17)30344-3_bib14) 2011; 170 Geoghegan (10.1016/S2214-109X(17)30344-3_bib16) 2017; 195 Nasreen (10.1016/S2214-109X(17)30344-3_bib3) 2014; 9 Zhang (10.1016/S2214-109X(17)30344-3_bib7) 2013; 6 Shay (10.1016/S2214-109X(17)30344-3_bib8) 2001; 183 Moyes (10.1016/S2214-109X(17)30344-3_bib18) 2013; 208 10.1016/S2214-109X(17)30344-3_bib23 10.1016/S2214-109X(17)30344-3_bib22 Mazur (10.1016/S2214-109X(17)30344-3_bib28) 2015; 3 Hall (10.1016/S2214-109X(17)30344-3_bib15) 2013; 132 Leung (10.1016/S2214-109X(17)30344-3_bib17) 2014; 42 El Kholy (10.1016/S2214-109X(17)30344-3_bib9) 2013; 55 Modjarrad (10.1016/S2214-109X(17)30344-3_bib21) 2016; 34 Lee (10.1016/S2214-109X(17)30344-3_bib10) 2016; 49 Vizcarra-Ugalde (10.1016/S2214-109X(17)30344-3_bib13) 2016; 35 Berger (10.1016/S2214-109X(17)30344-3_bib25) 2009; 37 Thorburn (10.1016/S2214-109X(17)30344-3_bib11) 2009; 94 Byington (10.1016/S2214-109X(17)30344-3_bib24) 2014; 135 Nair (10.1016/S2214-109X(17)30344-3_bib29) 2013; 381 Lozano (10.1016/S2214-109X(17)30344-3_bib1) 2012; 380 Chi (10.1016/S2214-109X(17)30344-3_bib26) 2011; 110 28986050 - Lancet Glob Health. 2017 Dec;5(12 ):e1190 28911753 - Lancet Glob Health. 2017 Oct;5(10 ):e951-e952 |
References_xml | – volume: 183 start-page: 16 year: 2001 end-page: 22 ident: bib8 article-title: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997 publication-title: J Infect Dis – volume: 37 start-page: 109 year: 2009 end-page: 116 ident: bib25 article-title: Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005) publication-title: Infection – volume: 34 start-page: 2865 year: 2016 end-page: 2869 ident: bib20 article-title: Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015 publication-title: Vaccine – volume: 59 start-page: 586 year: 2005 end-page: 590 ident: bib6 article-title: Mortality in children from influenza and respiratory syncytial virus publication-title: J Epidemiol Community Health – reference: WHO. Child growth standards. – volume: 35 start-page: 1199 year: 2016 end-page: 1203 ident: bib13 article-title: Intensive care unit admission and death rates of infants admitted with respiratory syncytial virus lower respiratory tract infection in Mexico publication-title: Pediatr Infect Dis J – volume: 195 start-page: 96 year: 2017 end-page: 103 ident: bib16 article-title: Mortality due to respiratory syncytial virus: burden and risk factors publication-title: Am J Respir Crit Care Med – volume: 55 start-page: 283 year: 2013 end-page: 288 ident: bib9 article-title: Morbidity and outcome of severe respiratory syncytial virus infection publication-title: Pediatr Int – volume: 49 start-page: 737 year: 2016 end-page: 742 ident: bib10 article-title: Risk factors associated with death in patients with severe respiratory syncytial virus infection publication-title: J Microbiol Immunol Infect – reference: The World Bank. Country and lending groups. – volume: 35 start-page: e229 year: 2016 end-page: e238 ident: bib27 article-title: Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review publication-title: Pediatr Infect Dis J – volume: 9 start-page: e89978 year: 2014 ident: bib3 article-title: Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June–October 2010 publication-title: PLoS One – volume: 303 start-page: 2051 year: 2010 end-page: 2057 ident: bib2 article-title: Viral etiology of severe pneumonia among Kenyan infants and children publication-title: JAMA – volume: 6 start-page: 447 year: 2013 ident: bib7 article-title: Respiratory syncytial virus-associated intensive care unit admission in children in southern China publication-title: BMC Res Notes – volume: 208 start-page: S217 year: 2013 end-page: S226 ident: bib18 article-title: Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011 publication-title: J Infect Dis – volume: 26 start-page: 2175 year: 2010 end-page: 2181 ident: bib12 article-title: Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children publication-title: Curr Med Res Opin – volume: 3 start-page: 888 year: 2015 end-page: 900 ident: bib28 article-title: Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics publication-title: Lancet Respir Med – reference: (accessed May 3, 2016). – volume: 6 start-page: e18176 year: 2011 ident: bib4 article-title: Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004–2008 publication-title: PLoS One – volume: 42 start-page: 343 year: 2014 end-page: 350 ident: bib17 article-title: Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children publication-title: Infection – year: 2017 ident: bib5 article-title: Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study publication-title: Lancet – volume: 132 start-page: e341 year: 2013 end-page: e348 ident: bib15 article-title: Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age publication-title: Pediatrics – volume: 380 start-page: 2095 year: 2012 end-page: 2128 ident: bib1 article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – reference: / – volume: 135 start-page: e24 year: 2014 end-page: e31 ident: bib24 article-title: Respiratory syncytial virus-associated mortality in hospitalized infants and young children publication-title: Pediatrics – volume: 110 start-page: 388 year: 2011 end-page: 396 ident: bib26 article-title: Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007 publication-title: J Formos Med Assoc – volume: 94 start-page: 99 year: 2009 end-page: 103 ident: bib11 article-title: Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection publication-title: Arch Dis Child – volume: 208 start-page: S197 year: 2013 end-page: S206 ident: bib19 article-title: Respiratory syncytial virus infection in Guatemala, 2007–2012 publication-title: J Infect Dis – volume: 170 start-page: 907 year: 2011 end-page: 913 ident: bib14 article-title: The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study publication-title: Eur J Pediatr – volume: 381 start-page: 1380 year: 2013 end-page: 1390 ident: bib29 article-title: Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis publication-title: Lancet – volume: 34 start-page: 190 year: 2016 end-page: 197 ident: bib21 article-title: WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015 publication-title: Vaccine – volume: 208 start-page: S217 year: 2013 ident: 10.1016/S2214-109X(17)30344-3_bib18 article-title: Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011 publication-title: J Infect Dis doi: 10.1093/infdis/jit479 – ident: 10.1016/S2214-109X(17)30344-3_bib22 – volume: 34 start-page: 190 year: 2016 ident: 10.1016/S2214-109X(17)30344-3_bib21 article-title: WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015 publication-title: Vaccine doi: 10.1016/j.vaccine.2015.05.093 – volume: 170 start-page: 907 year: 2011 ident: 10.1016/S2214-109X(17)30344-3_bib14 article-title: The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study publication-title: Eur J Pediatr doi: 10.1007/s00431-010-1376-3 – volume: 135 start-page: e24 year: 2014 ident: 10.1016/S2214-109X(17)30344-3_bib24 article-title: Respiratory syncytial virus-associated mortality in hospitalized infants and young children publication-title: Pediatrics doi: 10.1542/peds.2014-2151 – volume: 380 start-page: 2095 year: 2012 ident: 10.1016/S2214-109X(17)30344-3_bib1 article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61728-0 – volume: 26 start-page: 2175 year: 2010 ident: 10.1016/S2214-109X(17)30344-3_bib12 article-title: Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children publication-title: Curr Med Res Opin doi: 10.1185/03007995.2010.505126 – volume: 303 start-page: 2051 year: 2010 ident: 10.1016/S2214-109X(17)30344-3_bib2 article-title: Viral etiology of severe pneumonia among Kenyan infants and children publication-title: JAMA doi: 10.1001/jama.2010.675 – volume: 6 start-page: 447 year: 2013 ident: 10.1016/S2214-109X(17)30344-3_bib7 article-title: Respiratory syncytial virus-associated intensive care unit admission in children in southern China publication-title: BMC Res Notes doi: 10.1186/1756-0500-6-447 – volume: 37 start-page: 109 year: 2009 ident: 10.1016/S2214-109X(17)30344-3_bib25 article-title: Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005) publication-title: Infection doi: 10.1007/s15010-008-8130-z – volume: 195 start-page: 96 year: 2017 ident: 10.1016/S2214-109X(17)30344-3_bib16 article-title: Mortality due to respiratory syncytial virus: burden and risk factors publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201603-0658OC – volume: 381 start-page: 1380 year: 2013 ident: 10.1016/S2214-109X(17)30344-3_bib29 article-title: Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(12)61901-1 – volume: 9 start-page: e89978 year: 2014 ident: 10.1016/S2214-109X(17)30344-3_bib3 article-title: Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June–October 2010 publication-title: PLoS One doi: 10.1371/journal.pone.0089978 – volume: 208 start-page: S197 year: 2013 ident: 10.1016/S2214-109X(17)30344-3_bib19 article-title: Respiratory syncytial virus infection in Guatemala, 2007–2012 publication-title: J Infect Dis doi: 10.1093/infdis/jit517 – volume: 59 start-page: 586 year: 2005 ident: 10.1016/S2214-109X(17)30344-3_bib6 article-title: Mortality in children from influenza and respiratory syncytial virus publication-title: J Epidemiol Community Health doi: 10.1136/jech.2004.026450 – volume: 94 start-page: 99 year: 2009 ident: 10.1016/S2214-109X(17)30344-3_bib11 article-title: Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection publication-title: Arch Dis Child doi: 10.1136/adc.2008.139188 – volume: 132 start-page: e341 year: 2013 ident: 10.1016/S2214-109X(17)30344-3_bib15 article-title: Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age publication-title: Pediatrics doi: 10.1542/peds.2013-0303 – volume: 35 start-page: e229 year: 2016 ident: 10.1016/S2214-109X(17)30344-3_bib27 article-title: Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000001163 – ident: 10.1016/S2214-109X(17)30344-3_bib23 – volume: 6 start-page: e18176 year: 2011 ident: 10.1016/S2214-109X(17)30344-3_bib4 article-title: Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004–2008 publication-title: PLoS One doi: 10.1371/journal.pone.0018176 – volume: 183 start-page: 16 year: 2001 ident: 10.1016/S2214-109X(17)30344-3_bib8 article-title: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997 publication-title: J Infect Dis doi: 10.1086/317655 – volume: 49 start-page: 737 year: 2016 ident: 10.1016/S2214-109X(17)30344-3_bib10 article-title: Risk factors associated with death in patients with severe respiratory syncytial virus infection publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2014.08.020 – volume: 34 start-page: 2865 year: 2016 ident: 10.1016/S2214-109X(17)30344-3_bib20 article-title: Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015 publication-title: Vaccine doi: 10.1016/j.vaccine.2016.02.078 – volume: 55 start-page: 283 year: 2013 ident: 10.1016/S2214-109X(17)30344-3_bib9 article-title: Morbidity and outcome of severe respiratory syncytial virus infection publication-title: Pediatr Int doi: 10.1111/ped.12051 – volume: 42 start-page: 343 year: 2014 ident: 10.1016/S2214-109X(17)30344-3_bib17 article-title: Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children publication-title: Infection doi: 10.1007/s15010-013-0557-1 – volume: 35 start-page: 1199 year: 2016 ident: 10.1016/S2214-109X(17)30344-3_bib13 article-title: Intensive care unit admission and death rates of infants admitted with respiratory syncytial virus lower respiratory tract infection in Mexico publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000001262 – volume: 110 start-page: 388 year: 2011 ident: 10.1016/S2214-109X(17)30344-3_bib26 article-title: Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007 publication-title: J Formos Med Assoc doi: 10.1016/S0929-6646(11)60057-0 – volume: 3 start-page: 888 year: 2015 ident: 10.1016/S2214-109X(17)30344-3_bib28 article-title: Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(15)00255-6 – year: 2017 ident: 10.1016/S2214-109X(17)30344-3_bib5 article-title: Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study publication-title: Lancet doi: 10.1016/S0140-6736(17)30938-8 – reference: 28986050 - Lancet Glob Health. 2017 Dec;5(12 ):e1190 – reference: 28911753 - Lancet Glob Health. 2017 Oct;5(10 ):e951-e952 |
SSID | ssj0000993277 |
Score | 2.52998 |
Snippet | Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are... Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV... Background: Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV... |
SourceID | doaj pubmedcentral csuc proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e984 |
SubjectTerms | Child, Preschool Children Female Global Health - statistics & numerical data Humans Infant Infant, Newborn Infants Malalties de l'aparell respiratori Male Respiratory organs diseases Respiratory Syncytial Virus Infections - mortality Retrospective Studies |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnpAQ4k14yUgcWqTQxM-YG69SIR4SpWhvlu046qKShSSL1H_POE7SDRyWA4ccYmes2DOZ-Rx7PiP0xFQys4rkKYQqmrKSqlRVzqWCZNwoxqzs_3d8-CiOTti7JV9uHfUV9oRFeuA4cAcirypaAY4WyjFXKOsFJZYRKyXnnvapexDztiZT3yLuoaQ_dpGQnIGvUcuL9J2D46lwL5f7NLDepXQWmBau3biBxn8Wpv6GoX_uptwKT4fX0NUBV-IXsT_X0SVf30BX4k85HHONbqKfkeEfNxfr67g9B_cKn_kZ_rVqNm1qBn35En_voTnAdLyq8XlwC3jM_cZ7n4-_4ref3r_ef44NNNg16zFpEzuIjDiYtm9voZPDN19eHaXDmQupE0R1KS8hvvOKcMuYLyteAuICkECVCUukRnlbZIGSDVCML7KKWA_PglugUG5Kl9HbaFGva38XYQ-VzAgQqUxgabMcJne8LEpnDSjQJ4iNA67dQEgezsU409POs6CnsEa-1LnUvZ40TdCzSexHZOTYJfA0aFNDBPGNM50OjNrTTbhIJokG3COkStDLoPOp5fBsXwA2qQeb1LtsMkFitBg9JriCS4aGVrtetZgEBwQUkc2_iD4eTVODhwjLPqb2602rcxX8tKIqS9CdaKpT90AjeS4FS5CcGfGs__OaenXas5AHqjqasXv_Y8Duo8skwKV-k-QDtOiajX8IYK-zj_rv-jcd3Eos priority: 102 providerName: Directory of Open Access Journals |
Title | Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2214109X17303443 https://dx.doi.org/10.1016/S2214-109X(17)30344-3 https://www.ncbi.nlm.nih.gov/pubmed/28911764 https://www.proquest.com/docview/1940049390 https://recercat.cat/handle/2072/293679 https://pubmed.ncbi.nlm.nih.gov/PMC5599304 https://doaj.org/article/61ff3f55069c4c89be632b42b7755e39 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwELaqd0JCiLI-lspIHFqk8BLbWcyNFkqFWCRKUW6W7TglUslrkzyk_ntmnKUEDkUccojjGcWZ8cwXe2ZMyHNdpqGRLArAVfFAFFwGsrQ2SFgYaymESf16x8dPydGJeJ_H-RY5GHNhMKxysP29TffWemhZDV9zdV5Vq2PGMEZR5hEoKRcCK35ykfkkvnx_WmcBBMSZP4AR-wdIcJXI0zPxjbtRuuf5BHzmoha23dihoP_MYf0NSP-Mq_zNUR3eJrcGhElf94PYJluuvkNu9stztM86uksu-lr_tLnaaaftJRhamPBn9GfVbNpAD5JzBf3hQToAdlrV9BINBB2zwOnul-Nv9N3nD2_2XlENDLtmPaZvUgs-kqKSu_YeOTl8-_XgKBhOXwhswmQXxAV4-rhksRHCFWVcAPYCuMClxs1SLZ3JQizOBnjGZWHJjIO-YCA4tOvChvw-WdTr2j0k1MFDoRMgKTXWazMx_ObFRVZYo41gbknE-MGVHUqT4wkZZ2qKQUM54W55rqJUeTkpviQvJ7LzvjbHdQQvUJoK9Mo1VncKa2tPN3ixMGUKEFCSyiXZR5lPnLGvb1g3p2pQRJVEZclL-MtLpBU2k8YlnMGQTJrGsePAJBk1Ro2prmCcgVF13atmE-FsPvwL6bNRNRXYCtwA0rVbb1oVSbTYkstwSR70qjoNDyQSRWkiliSdKfFs_PMndfXd1yPHonU8FI_-_5UfkxsM4ZIPknxCFl2zcU8B7HVmxy-S7Pg5_QumqUv1 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbKcgAJId4sTyNxaJHCJrYTr7nRQtnCtkj0odwsx3EgUsmW7C5S_z0zzqMEDkUccoiTGcWZ8cxne2ZMyEtTyDBTLArAVfFA5FwFqrA2SFgYGyVEJv16x_5BMjsWH9M43SA7XS4MhlW2tr-x6d5aty2T9m9OzspycsgYxiiqNAIl5ULwK-QqoAGJo3Mv3e4XWgACceZPYESCACkuMnkaLr5xM5JbnlHABz5qZJdr21b0H3isvxHpn4GVv3mq3VvkZgsx6dumF7fJhqvukBvN-hxt0o7ukh9NsX9aX2y10-U5WFoY8af0Z1mvl4FpRedy-t2jdEDstKzoOVoI2qWB080vhyf0w-f5u6031ADDVb3o8jepBSdJUcvd8h453n1_tDML2uMXApswtQriHFx9XLA4E8LlRZwD-AK8wJXB3VKjXDYNsTobABo3DQuWOXgXLASHdpPbkN8no2pRuYeEOngoTAIkhcGCbVkM87w4n-Y2M5lgbkxE98O1bWuT4xEZp7oPQkM54XZ5qiOpvZw0H5PXPdlZU5zjMoJXKE0NiuVqa1Yai2v3N3ixUDINECiRaky2UeY9Z3zXNyzqr7rVRJ1ERcELmOYlygo7VZlLOIMuZVLGsePAJOk0Rne5rmCdgVF52adOe8LBgPgX0hedamowFrgDZCq3WC91pNBkK67CMXnQqGrfPZBIFMlEjIkcKPGg_8MnVfnNFyTHqnU8FI_-_5Ofk2uzo_25nu8dfHpMrjPETj5i8gkZreq1ewrIb5U98yP7F3yATiA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+respiratory+syncytial+virus-associated+mortality+in+young+children+%28RSV+GOLD%29%3A+a+retrospective+case+series&rft.jtitle=The+Lancet+global+health&rft.au=Scheltema%2C+Nienke+M&rft.au=Gentile%2C+Angela&rft.au=Lucion%2C+Florencia&rft.au=Nokes%2C+D+James&rft.date=2017-10-01&rft.issn=2214-109X&rft.eissn=2214-109X&rft.volume=5&rft.issue=10&rft.spage=e984&rft_id=info:doi/10.1016%2FS2214-109X%2817%2930344-3&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-109X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-109X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-109X&client=summon |